Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.47 |
| ▸ | METAP2 | P50579 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.43 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.42 |
| ▸ | FEN1 | P39748 | 2/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28048584 | 0.98 | DCTPP1 (0.52) | DCTPP1NPY5RMETAP2IDO1CYP1A2 | |
| SCHEMBL19980775 | 0.88 | DCTPP1 (0.48) | DCTPP1NPY5RMETAP2IDO1CYP1A2 | |
| SCHEMBL16526727 | 0.85 | TGFBR1 (0.54) | DCTPP1NPY5RMETAP2IDO1CYP1A2 | |
| SCHEMBL16526786 | 0.85 | DCTPP1 (0.46) | DCTPP1NPY5RMETAP2IDO1CYP1A2 | |
| SCHEMBL6527857 | 0.85 | DCTPP1 (0.45) | DCTPP1NPY5RCYP1A2ADRA1AADRA1B | |
| SCHEMBL12853973 | 0.83 | ALOX5AP (0.50) | DCTPP1METAP2CYP1A2CYP2C19ADRA1A | |
| SCHEMBL12853984 | 0.83 | ALOX5AP (0.50) | DCTPP1METAP2CYP1A2CYP2C19ADRA1A | |
| SCHEMBL3424160 | 0.81 | IDO1 (0.55) | METAP2IDO1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL17194890 | 0.79 | MAPK1 (0.43) | DCTPP1NPY5RCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL28129242 | 0.79 | DCTPP1 (0.41) | DCTPP1NPY5RMETAP2CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105418686-A | Pyrazine phosphorescent iridium complex, preparation method and application thereof | CHINA BEIJING BEIDA JUBANG SCIENCE & TECH CO LTD | 2016-03-23 | — | — | CN | claimed |
| CN-103221404-A | Nitrogen heterocyclic compounds useful as PDE10 inhibitors | AMGEN INC | 2013-07-24 | — | — | CN | claimed |
| CN-102164896-A | Phenethylamide derivatives and their heterocyclic analogues | ACTELION PHARMACEUTICALS LTD | 2011-08-24 | — | — | CN | claimed |
| EP-0069445-A1 | Process for making benzimidazoles | UNIROYAL, INC. (US) | 1983-01-12 | — | — | EP | claimed |
| WO-2026088070-A1 | COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20250114374-A1 | BCL-2 INHIBITORS | NEWAVE PHARMACEUTICAL INC. | 2025-04-10 | — | — | US | disclosed |
| US-11825734-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-21 | — | — | US | disclosed |
| WO-2023122000-A1 | BCL-2 INHIBITORS | NEWAVE PHARMACEUTICAL INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| CN-113828342-B | Cu-Pd-CeO 2 /γ-Al 2 O 3 Preparation of @ NP catalyst and synthesis of benzopyrazine compounds | 浙江工业大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-111620529-B | Curing agent for sludge road and preparation method thereof | 广东工业大学 | 2022-08-16 | — | — | CN | disclosed |
| CN-113828342-A | Cu-Pd-CeO2/γ-Al2O3Preparation of @ NP catalyst and synthesis of benzopyrazine compounds | 浙江工业大学 | 2021-12-24 | — | — | CN | disclosed |
| CN-111620529-A | Curing agent for sludge road and preparation method thereof | 广东工业大学 | 2020-09-04 | — | — | CN | disclosed |
| US-20130079510-A1 | CYCLIC CARBODIIMIDE COMPOUND | TEIJIN LIMITED (JP) | 2013-03-28 | — | — | US | disclosed |
| US-20120115882-A1 | SPIRO AMINO COMPOUNDS SUITABLE FOR THE TREATMENT OF INTER ALIA SLEEP DISORDERS AND DRUG ADDICTION | ROTTAPHARM BIOTECH S.R.L. (IT) | 2012-05-10 | — | — | US | disclosed |
| WO-2011132051-A2 | TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2011-10-27 | — | — | WO | disclosed |
| CN-102164896-A | Phenethylamide derivatives and their heterocyclic analogues | ACTELION PHARMACEUTICALS LTD | 2011-08-24 | — | — | CN | disclosed |
| WO-2011006960-A1 | SPIRO AMINO COMPOUNDS SUITABLE FOR THE TREATMENT OF INTER ALIA SLEEP DISORDERS AND DRUG ADDICTION | ROTTAPHARM S.P.A. (IT) | 2011-01-20 | — | — | WO | disclosed |
| CN-101814583-A | Light-emitting element, light-emitting device, and electronic apparatus | SEMICONDUCTOR ENERGY LAB | 2010-08-25 | — | — | CN | disclosed |
| CN-101321773-A | Organometallic complex, and light-emitting element, light-emitting device, and electronic device using the organometallic complex | SEMICONDUCTOR ENERGY LAB (JP) | 2008-12-10 | — | — | CN | disclosed |
| CN-101270133-A | Organometallic complex, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LAB (JP) | 2008-09-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114374-A1 | BCL-2 INHIBITORS | BCL2, BCL2L1, BCL2L10 | DCTPP1 4686/4885NPY5R 229/4885METAP2 4229/4885 |
| US-11825734-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | DCTPP1 3266/4885NPY5R 4277/4885METAP2 3814/4885 |
| US-20120115882-A1 | SPIRO AMINO COMPOUNDS SUITABLE FOR THE TREATMENT OF INTER ALIA SLEEP DISORDERS AND DRUG ADDICTION | SLC1A1, SLC6A3, SLC1A2 | DCTPP1 4284/4885NPY5R 726/4885METAP2 2207/4885 |
| US-20130079510-A1 | CYCLIC CARBODIIMIDE COMPOUND | CNOT9, CNOT1, ARPC4 | DCTPP1 2119/4885NPY5R 1680/4885METAP2 3300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.